Endo Recalls Mislabelled Clonazepam Tablets Due to Overdose Risks
MALVERN, PA — Endo, Inc. (OTCQX: NDOI) has announced a voluntary recall of one lot of Clonazepam Orally Disintegrating Tablets, USP (C-IV) 0.25 mg. The recall affects tablets that may …
Endo Recalls Mislabelled Clonazepam Tablets Due to Overdose Risks Read More